期刊文献+

GnRH拮抗剂在体外受精-胚胎移植中的应用 被引量:1

The use of regimen of Gonadotropin-Releasing Hormone antagonist in patients who underwent in vitro fertilization
原文传递
导出
摘要 目的探讨促性腺激素释放激素(GnRH)拮抗剂方案在体外受精-胚胎移植(IVF-ET)促超排卵中的应用效果。方法回顾性比较分析本中心2006年8月~2007年8月接受IVF-ET助孕治疗的患者中采用GnRH拮抗剂方案的54例患者和采用GnRH激动剂长方案的135例患者,观察其临床效果。结果两组Gn用量、HCG日内膜厚度、受精率、卵裂率之间比较无显著性差异;两组患者Gn使用天数、HCG日E2值、获卵数、冷冻率、种植率、妊娠率、OHSS发生率之间比较有显著性差异。结论GnRH拮抗剂联合促性腺激素促超排卵方案缩短用药时间,减少费用,并可显著降低OHSS的发生率,但冷冻率、妊娠率较GnRH激动剂长方案偏低。 Objective : To evaluate the efficacy of the gonadotropin - releasing hormone antagonist protocol and the gonadotropin - releasing hormone agunist protocol of patients who underwent in vitro fertilization. Methods : A retrospective analyse referred patients who subjected to IVF between August 2006 and August 2007 were divided into two group and compare their clinic result. The study group: 54 patients were subjected to a protocol of gonadotropin -releasing hormone antagonist. The control group: 155 patients were subjected to a long protocol of gonadotropin - releasing hormone agonist. Results : The two groups were similar with respect to the doses of gonadotrophins ( HMG and/or rFSH) , the thickness of endometrium, the ratio of fertilization and the ratio of cleavage. Significant differences ( P 〈 0. 05) were found regarding the duration of administration, the profile of hormone level on the day of HCG adminis- tration ( E2 ) , the number of retrieved oocyte, the rate of embryo freezing, the implantation rate of embryo, the pregnancy rate and the incidence rate of OHSS. Conclusion : We demonstrated that regimen of GnRH antagonist in patients undergoing IVF shorten the du- ration of administration and greatly reduced the treatment cost, especially the incidence rate of OHSS was decreased significantly. But the rate of embryo freezing and the pregnancy rate were lower compared With the regimen of GnRH agonist long protocol.
出处 《中国优生与遗传杂志》 2008年第9期111-112,125,共3页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献10

  • 1Borm G, Mannaerts B. Treatment with the gonadotrophin - releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient :results of a controlled, randomized, multicentre trial [ J ]. Hum Reorod.2000.15(7) :1490 - 1498.
  • 2AI - Inany H, Aboulghar M. GnRH antagonist in assisted reprocluction: a Cochrane review [ J ]. Hum Reprod,2002,17 (4) :874 - 885.
  • 3周士平,王树玉,黄醒华.辅助生育技术中常用的促超排卵药物[J].中国优生与遗传杂志,2003,11(1):78-80. 被引量:10
  • 4Broekwans F J, Weima SM&te Velde ER. A randomized comparison of two ovarian stimulation protocols with gonadotropin - releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle - stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol [ J]. J Clin Endocrinol Metab,2003,88 (9) :4510.
  • 5Lindheim SR, Morales AJ. GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles [J] Human Reprod,2003,18( 10): 2048-2051.
  • 6Simon C, Oberye J, Bellver J, et al. Similar endometrial development in oocyte donors treated with either high - or standard'- dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles[ J]. Human Reprod,2005,20(12) :3318 -3327.
  • 7Tarlatzis BC, et al. GnRI-I antagonists in ovarian stimulation for IVF [ J ]. Hum Reprod Update,2006,12 (7) :333 - 340.
  • 8Nikolettos N, et al. Gonadotropin - releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders [ J ]. Eur J Obstet&Gynecol Reprod Biol,2001,97 ( 2 ) : 202 - 207.
  • 9阳翎,高士友,邓朝晖,唐慧珍,陈辉莲,李燕,汤倩倩.多剂量促性腺激素释放激素拮抗剂在体外受精—胚胎移植促超排卵中的应用效果[J].医学临床研究,2007,24(4):535-537. 被引量:6
  • 10Ragni G,et al. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of Ovarian hyperstimulation syndrome [ J ]. Human Reprod, 2005,20 (9) : 2421 - 2425.

二级参考文献20

  • 1庄广伦,翁世湘,周灿权.小剂量生长激素在体外受精超排卵周期中的作用[J].中华妇产科杂志,1994,29(8):471-474. 被引量:36
  • 2[1]Biljan MM, Mahutte NG, Tulandi T, et al. Prospective randomized double-blind trail of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end ovgans. Fertil Steril, 1999, 71(4):633-638
  • 3[3]De Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrone. Fertil Steril, 1999, 72(2) :282-285
  • 4[4]Branigan EF, Estes MA. Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by reprent CC treatment. Fertil Steril, 1999, 71(3) :544-546
  • 5[5]Matikainen T, DE Leew R, Mannaerts B, et al. Circulating bioactive and immunoreactive recombinant human follicle simulating hormone after administration to gonadotropin deficient subjects. Fertil Steril, 1994, 61:62-69
  • 6[6]De Leew R, Mulders J, Voortman G, et al. Structure function relationship of recombinant follicle stimulating hormone. Hum Reprod,1996, 2: 361-369
  • 7[7]Hoomans EHM, Andersen AN, et al. A prospective, randomized clinical trail comparing 150IU recombinant follicles stimulating hormone( Metrodin-HP)in a fixed dose regimen in women undergoing ovarian stimulation. Hum Reprod, 1999, 14:2442-2447
  • 8[8]Out HJ, Mannaerts BMJL, Driessen SGAT, et al. A prospective,randomized assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone in in-vitro fertilization. Hum Reprod, 1995, 10: 2534-2540
  • 9[9]Jinno M, Satou M, Ubukata Y, et al. Administration of hCG for IVF-ET based on the serum LH concentration: the importance of synchronization with endogenous LH rises [J ]. Fertil Steril, 1995,63(4) :859-865
  • 10[10]Priou G. Management of ovarian hyperstimulation syndrome during IVF program [J ]. Contracept Fertil Sex, 1996, 24(9): 647-649

共引文献14

同被引文献11

  • 1Porter RN, Smith W, Craft IL,et al. Induction of ovulation for in-vitro fertilisation using huserelin and gonadotropins[J]. Lancet ,1984,2:1284-1285.
  • 2Olivennes F, Fanchin R, Bouchard P, et al. Scheduled administration of a gonadot rophin-releasing hormone antagonist(Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study[J]. Hum Reprod,1995 ,10 :1382-1386.
  • 3Nelson LR, Fujimoto VY, Jaffe RB et al. Suppression of follicular phase pituitary-gonadal function by a potent new gonadotrophin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix) [J ]. Fertil Steril, 1995,63:963-969. '.
  • 4Kolibianakis EM, Collins J, Tarlatzis BC, et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis [J] Hum Reprod Update, 2006,12 : 651-671,.
  • 5Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology[CD]. Cochrane Database Syst Rev, 2011 : CD001750.
  • 6Qiao J,Lu GX,Zhang HW,et al. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates [OL]. Gynecol Endocrinol, 2012 Mar20;Early Online:1-5. [Epub ahead of print].
  • 7The ganirelix dose-finding study group. A double-blind, randomized,dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with reeombinant follicle stimulating hormone(Puregon)[J]. Hum Reprod,1998 ,13:3023-3031.
  • 8Simon C, Oberye J, Bellver J, et al. , Similar endometrial development in oocyte donors treated with either high-or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cysles[J]. Hum Reprod, 2005, 20:3318-3327.
  • 9Lainas TG,Sfontouris IA,Zorzovilis IZ et al. ,Flexible GnRH antagonist protocol versus GnRH agonist long protocol inpatients with polycystic ovary syndrome treated for IVF a prospective randomised controlled trial (RCT) [J]. Hum Reprod, 2010,25 : 683-689.
  • 10Kim CH,Moon JW, Kang H J, et at. Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystie ovary syndrome undergoing IVF/ICSI[J]. Clin Exp Reprod Med, 2012 39 : 22-27.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部